$9.14
0.424.82%
Ultimo aggiornamento: Nov 21, 11:04 AM
Il short interest su Cullinan Therapeutics Inc (NASDAQ:CGEM) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 6.63M a 6.51M. Questo rappresenta il 12.75% delle azioni disponibili pubblicamente dell'azienda.
Sulla base del volume medio recente di 1.08M azioni scambiate al giorno, ci vorrebbero 6 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
CGEM | Cullinan Therapeutics, Inc. Co | 10/31/2025 | 11/11/2025 | 12.75% | 51,068,944 | 6,509,523 | 1,084,182 | 6 | |
CGEM | Cullinan Therapeutics, Inc. Co | 10/15/2025 | 10/24/2025 | 12.98% | 51,067,076 | 6,629,787 | 1,832,351 | 3.62 | |
CGEM | Cullinan Therapeutics, Inc. Co | 09/30/2025 | 10/09/2025 | 11.94% | 51,067,076 | 6,099,492 | 665,799 | 9.16 | |
CGEM | Cullinan Therapeutics, Inc. Co | 09/15/2025 | 09/24/2025 | 12.10% | 51,067,076 | 6,181,110 | 736,386 | 8.39 | |
CGEM | Cullinan Therapeutics, Inc. Co | 08/29/2025 | 09/10/2025 | 12.23% | 51,067,076 | 6,244,014 | 363,732 | 17.17 | |
CGEM | Cullinan Therapeutics, Inc. Co | 08/15/2025 | 08/26/2025 | 11.45% | 51,067,076 | 5,845,639 | 343,344 | 17.03 | |
CGEM | Cullinan Therapeutics, Inc. Co | 07/31/2025 | 08/11/2025 | 12.62% | 51,067,076 | 6,445,305 | 325,817 | 19.78 | |
CGEM | Cullinan Therapeutics, Inc. Co | 07/15/2025 | 07/24/2025 | 11.54% | 51,007,352 | 5,884,616 | 281,142 | 20.93 | |
CGEM | Cullinan Therapeutics, Inc. Co | 06/30/2025 | 07/10/2025 | 11.74% | 51,007,352 | 5,990,144 | 438,820 | 13.65 | |
CGEM | Cullinan Therapeutics, Inc. Co | 06/13/2025 | 06/25/2025 | 11.69% | 51,007,352 | 5,960,723 | 313,851 | 18.99 | |
CGEM | Cullinan Therapeutics, Inc. Co | 05/30/2025 | 06/10/2025 | 12.12% | 51,007,352 | 6,181,783 | 350,582 | 17.63 | |
CGEM | Cullinan Therapeutics, Inc. Co | 05/15/2025 | 05/27/2025 | 11.73% | 51,007,352 | 5,985,004 | 533,771 | 11.21 | |
CGEM | Cullinan Therapeutics, Inc. Co | 04/30/2025 | 05/09/2025 | 14.66% | 51,007,352 | 7,479,137 | 424,826 | 17.61 | |
CGEM | Cullinan Therapeutics, Inc. Co | 04/15/2025 | 04/25/2025 | 15.82% | 50,514,850 | 7,992,466 | 571,080 | 14 | |
CGEM | Cullinan Therapeutics, Inc. Co | 03/31/2025 | 04/09/2025 | 16.88% | 50,514,850 | 8,527,373 | 396,697 | 21.5 | |
CGEM | Cullinan Therapeutics, Inc. Co | 03/14/2025 | 03/25/2025 | 17.17% | 50,514,850 | 8,674,784 | 448,408 | 19.35 | |
CGEM | Cullinan Therapeutics, Inc. Co | 02/28/2025 | 03/11/2025 | 17.14% | 50,514,850 | 8,655,955 | 432,794 | 20 | |
CGEM | Cullinan Therapeutics, Inc. Co | 02/14/2025 | 02/26/2025 | 17.47% | 50,229,617 | 8,773,501 | 420,170 | 20.88 | |
CGEM | Cullinan Therapeutics, Inc. Co | 01/31/2025 | 02/11/2025 | 17.39% | 50,229,617 | 8,732,969 | 421,645 | 20.71 | |
CGEM | Cullinan Therapeutics, Inc. Co | 01/15/2025 | 01/27/2025 | 19.47% | 50,229,617 | 9,780,040 | 587,574 | 16.64 | |
CGEM | Cullinan Therapeutics, Inc. Co | 12/31/2024 | 01/10/2025 | 19.54% | 50,229,617 | 9,816,622 | 621,496 | 15.8 | |
CGEM | Cullinan Therapeutics, Inc. Co | 12/13/2024 | 12/24/2024 | 19.22% | 50,229,617 | 9,652,522 | 520,456 | 18.55 | |
CGEM | Cullinan Therapeutics, Inc. Co | 11/29/2024 | 12/10/2024 | 18.23% | 50,229,617 | 9,157,765 | 541,204 | 16.92 | |
CGEM | Cullinan Therapeutics, Inc. Co | 11/15/2024 | 11/26/2024 | 17.34% | 50,229,617 | 8,709,252 | 611,640 | 14.24 | |
CGEM | Cullinan Therapeutics, Inc. Co | 10/31/2024 | 11/11/2024 | 17.96% | 50,229,617 | 9,021,016 | 371,044 | 24.31 | |
CGEM | Cullinan Therapeutics, Inc. Co | 10/15/2024 | 10/24/2024 | 18.13% | 49,978,665 | 9,060,682 | 344,993 | 26.26 | |
CGEM | Cullinan Therapeutics, Inc. Co | 09/30/2024 | 10/09/2024 | 18.43% | 49,978,665 | 9,208,641 | 820,640 | 11.22 | |
CGEM | Cullinan Therapeutics, Inc. Co | 09/13/2024 | 09/24/2024 | 16.85% | 49,978,665 | 8,419,812 | 514,632 | 16.36 | |
CGEM | Cullinan Therapeutics, Inc. Co | 08/30/2024 | 09/11/2024 | 16.10% | 49,978,665 | 8,047,499 | 465,028 | 17.31 | |
CGEM | Cullinan Therapeutics, Inc. Co | 08/15/2024 | 08/26/2024 | 16.32% | 49,978,665 | 8,155,846 | 728,693 | 11.19 | |
CGEM | Cullinan Therapeutics, Inc. Co | 07/31/2024 | 08/09/2024 | 16.72% | 49,978,665 | 8,355,333 | 823,873 | 10.14 | |
CGEM | Cullinan Therapeutics, Inc. Co | 07/15/2024 | 07/24/2024 | 15.90% | 49,636,258 | 7,893,041 | 552,658 | 14.28 | |
CGEM | Cullinan Therapeutics, Inc. Co | 06/28/2024 | 07/10/2024 | 15.79% | 49,636,258 | 7,836,514 | 1,514,502 | 5.17 | |
CGEM | Cullinan Therapeutics, Inc. Co | 06/14/2024 | 06/26/2024 | 9.11% | 49,636,258 | 4,520,539 | 708,799 | 6.38 | |
CGEM | Cullinan Therapeutics, Inc. Co | 05/31/2024 | 06/11/2024 | 8.75% | 49,636,258 | 4,343,865 | 636,581 | 6.82 | |
CGEM | Cullinan Therapeutics, Inc. Co | 05/15/2024 | 05/24/2024 | 7.54% | 49,636,258 | 3,742,326 | 887,844 | 4.22 | |
CGEM | Cullinan Therapeutics, Inc. Co | 04/30/2024 | 05/09/2024 | 6.72% | 35,057,825 | 2,356,506 | 1,780,689 | 1.32 | |
CGEM | Cullinan Oncology, Inc. Common | 04/15/2024 | 04/24/2024 | 4.79% | 35,057,825 | 1,678,317 | 266,333 | 6.3 | |
CGEM | Cullinan Oncology, Inc. Common | 03/28/2024 | 04/09/2024 | 4.10% | 35,057,825 | 1,436,008 | 346,410 | 4.15 | |
CGEM | Cullinan Oncology, Inc. Common | 03/15/2024 | 03/26/2024 | 2.67% | 35,057,825 | 935,407 | 511,886 | 1.83 | |
CGEM | Cullinan Oncology, Inc. Common | 02/29/2024 | 03/11/2024 | 1.98% | 35,057,825 | 694,101 | 427,267 | 1.62 | |
CGEM | Cullinan Oncology, Inc. Common | 02/15/2024 | 02/27/2024 | 2.27% | 34,483,665 | 783,919 | 612,983 | 1.28 | |
CGEM | Cullinan Oncology, Inc. Common | 01/31/2024 | 02/09/2024 | 4.28% | 34,483,665 | 1,474,886 | 337,877 | 4.37 | |
CGEM | Cullinan Oncology, Inc. Common | 01/12/2024 | 01/24/2024 | 3.16% | 34,483,665 | 1,088,008 | 267,445 | 4.07 | |
CGEM | Cullinan Oncology, Inc. Common | 12/29/2023 | 01/10/2024 | 3.04% | 34,483,665 | 1,049,233 | 193,336 | 5.43 | |
CGEM | Cullinan Oncology, Inc. Common | 12/15/2023 | 12/27/2023 | 5.91% | 34,483,665 | 2,037,014 | 311,861 | 6.53 | |
CGEM | Cullinan Oncology, Inc. Common | 11/30/2023 | 12/11/2023 | 6.11% | 34,483,665 | 2,107,566 | 122,344 | 17.23 | |
CGEM | Cullinan Oncology, Inc. Common | 11/15/2023 | 11/27/2023 | 6.25% | 34,483,665 | 2,155,318 | 177,898 | 12.12 |
In cerca di azioni più vendute allo scoperto?